Company: Amgen Inc.
Ticker: AMGN
Form: 10-K
Filed: 2026-02-13
Fiscal Period: {"fp": "FY", "fy": 2025}

Question: What was Amgen Inc.'s net margin in fiscal year 2025?
Question Type: derived_ratio

Concept: NetIncomeLoss
RevenueFromContractWithCustomerExcludingAssessedTax
Answer (Numeric): 20.98
Answer (Display): 20.98%
Unit: percent

Evidence:
[{"chunk_id": "277", "equivalent_chunk_ids": ["277"], "section": "CONSOLIDATED STATEMENTS OF INCOME", "supports": ["numerator", "denominator"], "text": "Years ended December 31, 2025, 2024 and 2023\n(In millions, except per-share data)\nRevenues:\nProduct sales\n35,148\n32,026\n26,910\nOther revenues\n1,603\n1,398\n1,280\nTotal revenues\n36,751\n33,424\n28,190\nOperating expenses:\nCost of sales\n12,037\n12,858\n8,451\nResearch and development\n7,272\n5,964\n4,784\nSelling, general and administrative\n7,050\n7,096\n6,179\nOther\n1,312\nTotal operating expenses\n27,671\n26,166\n20,293\nOperating income\n9,080\n7,258\n7,897\nOther income (expense):\nInterest expense, net\n2,755\n3,155\n2,875\nOther income, net\n2,651\n2,833\nIncome before income taxes\n8,976\n4,609\n7,855\nProvision for income taxes\n1,265\n1,138\nNet income\n7,711\n4,090\n6,717\nEarnings per share:\nBasic\n14.33\n7.62\n12.56\nDiluted\n14.23\n7.56\n12.49\nWeighted-average shares used in the calculation of earnings per share:\nBasic\nDiluted\nSee accompanying notes.\nF-4\nAMGEN INC."}]

Derivation: {"denominator": "revenue", "denominator_value": 36751.0, "format": "percentage", "numerator": "net_income", "numerator_value": 7711.0, "op": "divide"}